EPISODE · Oct 28, 2021 · 1H 12M
TdC 112: Obesidade - Tratamento Medicamentoso
from Ta de Clinicagem · host tadeclinicagem
1º Encontro TdC - Simpósio Anual de Atualização em Clínica Médica Um dia inteiro de Clínica Médica, com temas cuidadosamente selecionados para responder à pergunta que mais importa: o que muda minha prática?Se você é residente, médico recém-formado, especialista ou estudante de Medicina e gosta da forma como o TdC discute medicina baseada em evidências, esperamos você em São Paulo no dia 22 de agosto.Garanta sua vaga através do link: https://www.tadeclinicagem.com.br/eventostdc/1-encontro-tdc/🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨Raphael e João recebem mais uma vez a Dra. Nathalie Santana, dessa vez para discutir o tratamento farmacológico da obesidade! Quais as indicações de tratamento farmacológico? Quais as opções on-label? Quais as diferenças de preço e potência das medicações? Isso e muito mais nesse episódio!Referências:1. Obesity in adults: Drug therapy Author:Leigh Perreault, MD Section Editor: F Xavier Pi-Sunyer, MD, MPH Deputy Editor: Lisa Kunins, MD2. ABESO - Diretrizes brasileiras de Obesidade 20163. SCHUTZ, Dominique Durrer et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obesity facts, v. 12, n. 1, p. 40-66, 2019.4. VA/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity5. AMERICAN DIABETES ASSOCIATION et al. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care, v. 44, n. Supplement 1, p. S15-S33, 2021.6. APOVIAN, Caroline M. et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, v. 100, n. 2, p. 342-362, 2015.7. WILDING, John PH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.8. JAMES, W. Philip T. et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. New England Journal of Medicine, v. 363, n. 10, p. 905-917, 2010.9. JAMES, W. Philip T. et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. The Lancet, v. 356, n. 9248, p. 2119-2125, 2000.10. YEH, James S.; KUSHNER, Robert F.; SCHIFF, Gordon D. Obesity and management of weight loss. New England Journal of Medicine, v. 375, n. 12, p. 1187-1189, 2016.11. KAHAN, Scott; MANSON, JoAnn E. Obesity treatment, beyond the guidelines: practical suggestions for clinical practice. Jama, v. 321, n. 14, p. 1349-1350, 2019.12. MCALLISTER, Emily J. et al. Ten putative contributors to the obesity epidemic. Critical reviews in food science and nutrition, v. 49, n. 10, p. 868-913, 200913. GBD 2015 OBESITY COLLABORATORS. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, v. 377, n. 1, p. 13-27, 2017.
What this episode covers
Raphael e João recebem mais uma vez a dra. Nathalie Santana, dessa vez para discutir o tratamento farmacológico da obesidade! Quais as indicações de tratamento farmacológico? Quais as opções on-label? Quais as diferenças de preço e potência das medicações? Isso e muito mais nesse episódio! REFERÊNCIAS 1. Obesity in adults: Drug therapy Author:Leigh Perreault, MD Section Editor: F Xavier Pi-Sunyer, MD, MPH Deputy Editor: Lisa Kunins, MD 2. ABESO - Diretrizes brasileiras de Obesidade 2016 3. SCHUTZ, Dominique Durrer et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obesity facts, v. 12, n. 1, p. 40-66, 2019. 4. VA/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity 5. AMERICAN DIABETES ASSOCIATION et al. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care, v. 44, n. Supplement 1, p. S15-S33, 2021. 6. APOVIAN, Caroline M. et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, v. 100, n. 2, p. 342-362, 2015. 7. WILDING, John PH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021. 8. JAMES, W. Philip T. et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. New England Journal of Medicine, v. 363, n. 10, p. 905-917, 2010. 9. JAMES, W. Philip T. et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. The Lancet, v. 356, n. 9248, p. 2119-2125, 2000. 10. YEH, James S.; KUSHNER, Robert F.; SCHIFF, Gordon D. Obesity and management of weight loss. New England Journal of Medicine, v. 375, n. 12, p. 1187-1189, 2016. 11. KAHAN, Scott; MANSON, JoAnn E. Obesity treatment, beyond the guidelines: practical suggestions for clinical practice. Jama, v. 321, n. 14, p. 1349-1350, 2019. 12. MCALLISTER, Emily J. et al. Ten putative contributors to the obesity epidemic. Critical reviews in food science and nutrition, v. 49, n. 10, p. 868-913, 2009 13. GBD 2015 OBESITY COLLABORATORS. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, v. 377, n. 1, p. 13-27, 2017.
NOW PLAYING
TdC 112: Obesidade - Tratamento Medicamentoso
No transcript for this episode yet
Similar Episodes
Sep 17, 2025 ·24m
Jun 12, 2025 ·20m
May 19, 2025 ·25m
Jan 10, 2025 ·28m
Jan 10, 2025 ·23m